- Home
- OMAB vs PCVX Comparison
OMAB vs PCVX Comparison
Compare OMAB & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMAB
- PCVX
- Stock Information
- Founded
- OMAB 1998
- PCVX 2013
- Country
- OMAB Mexico
- PCVX United States
- Employees
- OMAB N/A
- PCVX N/A
- Industry
- OMAB Aerospace
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- OMAB Consumer Discretionary
- PCVX Health Care
- Exchange
- OMAB Nasdaq
- PCVX Nasdaq
- Market Cap
- OMAB 5.0B
- PCVX 4.0B
- IPO Year
- OMAB 2006
- PCVX 2020
- Fundamental
- Price
- OMAB $98.62
- PCVX $45.28
- Analyst Decision
- OMAB Buy
- PCVX Strong Buy
- Analyst Count
- OMAB 4
- PCVX 8
- Target Price
- OMAB $102.50
- PCVX $114.17
- AVG Volume (30 Days)
- OMAB 79.7K
- PCVX 1.6M
- Earning Date
- OMAB 10-24-2025
- PCVX 11-05-2025
- Dividend Yield
- OMAB 4.04%
- PCVX N/A
- EPS Growth
- OMAB 6.38
- PCVX N/A
- EPS
- OMAB 0.75
- PCVX N/A
- Revenue
- OMAB $870,458,176.00
- PCVX N/A
- Revenue This Year
- OMAB $4.47
- PCVX N/A
- Revenue Next Year
- OMAB $13.50
- PCVX N/A
- P/E Ratio
- OMAB $16.45
- PCVX N/A
- Revenue Growth
- OMAB 8.86
- PCVX N/A
- 52 Week Low
- OMAB $62.06
- PCVX $27.66
- 52 Week High
- OMAB $116.26
- PCVX $116.00
- Technical
- Relative Strength Index (RSI)
- OMAB 33.94
- PCVX 66.85
- Support Level
- OMAB $98.82
- PCVX $43.12
- Resistance Level
- OMAB $103.51
- PCVX $45.69
- Average True Range (ATR)
- OMAB 2.75
- PCVX 1.67
- MACD
- OMAB -0.30
- PCVX -0.12
- Stochastic Oscillator
- OMAB 13.46
- PCVX 90.79
About OMAB Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
Grupo Aeroportuario del Centro Norte SAB de CV operates airports in the central region of Mexico. The airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park. Its reportable segments include its airports, the Terminal 2 NH Collection Hotel, the Hilton Garden Inn Hotel and the OMA-VYNMSA Industrial Park, individually, and information about its holding company and other companies is combined in the Others.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.